Masimo

Masimo Corporation is a global medical technology company founded in 1989 in Irvine, California. It specializes in developing and marketing innovative noninvasive patient monitoring technologies, medical devices, and sensors. The company's flagship technology, Masimo SET® (Signal Extraction Technology), has transformed pulse oximetry by providing accurate oxygen saturation measurements even during patient movement and low perfusion. Masimo's product range includes advanced pulse oximeters, patient monitoring systems, telehealth platforms, and wearable health devices. The introduction of rainbow SET technology allows for noninvasive measurement of additional parameters like hemoglobin and oxygen content. The company is recognized for its significant impact in healthcare, with its technologies used to monitor over 100 million patients globally and being the primary pulse oximetry technology in 17 of the top 20 U.S. hospitals. Masimo is publicly traded on the Nasdaq under the symbol MASI and employs over 7,000 people, generating around $800 million in annual revenue.

• Employees 3600
• Founded 1989
• Annual Revenue $2094400000
• Total Funding $207532642